Ashland Q3 profit beats on higher volume, pricing; cuts FY EPS forecast
Ashland Q3 profit beats on higher volume, pricing; cuts FY EPS forecast
Overview
US specialty ingredients maker's fiscal Q3 revenue rose 7%, beating analyst expectations
Adjusted EPS for fiscal Q3 beat consensus
Company reaffirmed full-year sales and Adjusted EBITDA guidance
Outlook
Ashland reaffirms full-year 2026 sales guidance of $1,835-$1,870 mln
Company maintains 2026 Adjusted EBITDA guidance at $385-$400 mln
Ashland revises adjusted EPS growth outlook to low-to-mid-single digit growth from mid-to-high-single digit growth, reflecting a higher tax rate associated with unfavorable discrete items
Result Drivers
VOLUME GROWTH - Co said sales volumes rose 6% year-over-year, with gains across all business units
LIFE SCIENCES DEMAND - Life Sciences segment saw double-digit sales growth, driven by broad-based pharma demand and continued momentum in differentiated products
PRICING ACTIONS - Co said pricing increased about 1% year-over-year, helping to recover higher raw material costs
Company press release: ID:nGNX7kGfGV
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $497 mln | $485.98 mln (8 Analysts) |
Q3 Adjusted EPS | Beat | $1.02 | $0.99 (10 Analysts) |
Q3 Net Income |
| $16 mln |
|
Q3 EPS |
| $0.35 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the diversified chemicals peer group is "buy"
Wall Street's median 12-month price target for Ashland Inc is $74.00, about 8.8% above its July 28 closing price of $68.01
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 13 three months ago
Reuters Recommended Reads
July 28 - Repligen Q2 revenue beats estimates on higher orders; raises outlook
July 28 - Ecolab raises annual profit forecast on pricing, high-tech demand
July 28 - Sherwin-Williams raises profit forecast, expects higher prices to drive growth
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Ashland
See all newsEvonik remains opposed to takeover offer after meeting BASF, says source familiar with the matter
Evonik still against takeover by BASF after talks, Handelsblatt reports
Evonik remains opposed to BASF bid after meeting, says person familiar with the matter (updated)
BASF, Evonik management held talks over weekend, says person familiar with matter
US RESEARCH ROUNDUP-Cencora, Dave, Uber